Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Corticosteroid Eyedrops Market From 2025 to 2029?

The market for corticosteroid eyedrops has seen substantial growth in recent years and is projected to expand from $8.36 billion in 2024 to $10.00 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this expansion during the historic period include an aging demographic, an upswing in eye inflammation cases, a rise in cataract surgeries, the proliferation of ophthalmology clinics, an increase in allergic conjunctivitis prevalence, and enhanced understanding of eye health.

Anticipated to witness robust growth in the coming years, the corticosteroid eyedrops market is projected to swell to $12.88 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.5%. Factors propelling growth in the said period include rising cases of diabetic eye troubles, mounting preference for minimally invasive procedures, increase in digital screen-induced eye weariness, extended reach of teleophthalmology, escalating chronic eye conditions, and a surge in worldwide surgical eye operations. Future market trends encompass nano-structured delivery systems, preservative-less formulations, intelligent packaging facilitating dosage monitoring, AI-enabled prescription platforms, and blended medications offering better bioavailability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25730&type=smp

What Elements Are Contributing To Growth In The Corticosteroid Eyedrops Market?

The escalating occurrence of illnesses affecting the eyes is set to drive the expansion of the corticosteroid eyedrops industry. Eye afflictions can deteriorate the eyes’ health and functionality, possibly causing vision issues or even blindness if not adequately treated. An increase in the use of screens is leading to a surge in eye diseases, causing digital eye strain and contributing to ailments like dry eyes and blurred vision. To manage eye illnesses, corticosteroid eyedrops are typically used as they curtail inflammation and alleviate symptoms like redness, swelling, and unease. For instance, the Joint Strategic Needs Assessment, a community health center in the UK, noted in their May 2024 report that around 2 million people in the UK are living with some level of vision loss. This figure is expected to rise to 2.7 million by 2030. Consequently, the surging occurrence of eye diseases is fueling the expansion of the corticosteroid eyedrops industry.

Which Segments Are Detailed In The Global Corticosteroid Eyedrops Market Report?

The corticosteroid eyedrops market covered in this report is segmented –

1) By Product Type: Topical Corticosteroid Eyedrops, Systemic Corticosteroid Eyedrops, Combination Therapy Eyedrops

2) By Delivery Device: Dropper Bottles, Spray Formulations, Ointments And Gels, Punctal Plugs

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By Application: Adult, Children

5) By End User: Hospitals, Specialty Clinics, Community Pharmacies, Online Pharmacies

Subsegments:

1) By Topical Corticosteroid Eyedrops: Prednisolone Acetate Eyedrops, Dexamethasone Eyedrops, Fluorometholone Eyedrops, Loteprednol Etabonate Eyedrops, Rimexolone Eyedrops

2) By Systemic Corticosteroid Eyedrops: Hydrocortisone-Based Eyedrops, Methylprednisolone-Based Eyedrops, Triamcinolone-Based Eyedrops, Betamethasone-Based Eyedrops

3) By Combination Therapy Eyedrops: Corticosteroid + Antibiotic Combination Eyedrops, Corticosteroid + Non-Steroidal Anti-Inflammatory Drug (NSAID) Eyedrops, Corticosteroid + Antihistamine Eyedrops, Corticosteroid + Antiglaucoma Agent Eyedrops

Which Emerging Trends And Strategic Shifts Are Shaping The Corticosteroid Eyedrops Market?

Primary players in the corticosteroid eyedrops market are directing their efforts towards securing regulatory approval to broaden their offerings and increase their market presence. These permissions from health agencies certify that the corticosteroid eyedrops conform to essential safety, effectiveness, and quality benchmarks prior to being promoted and prescribed. For example, in March 2024, Taiwan’s Formosa Pharmaceuticals Inc. and U.S.-based AimMax Therapeutics obtained FDA approval for clobetasol propionate ophthalmic suspension 0.05% (APP13007) to treat inflammation and pain after eye operations. This drug was made using Formosa’s APNT nanoparticle technology which enables effective drug delivery through a simple, twice-daily dose for 14 days without tapering. Clinical studies proved its potent anti-inflammatory impact, marking it as an emerging choice for corticosteroid treatments to control pain and swelling post eye surgery. Being the first ophthalmic corticosteroid with clobetasol and the first new steroid endorsed in this category in over a decade and a half, it signifies a remarkable progress in ocular corticosteroid treatment.

Who Are The Key Contributors To Growth In The Corticosteroid Eyedrops Market?

Major companies operating in the corticosteroid eyedrops market are Pfizer Inc., AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Santen Pharmaceutical Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Sunways Pvt. Ltd., FDC Limited, Alimera Sciences Inc., Eurocrit Labs International Pvt. Ltd., Entod Pharmaceuticals Pvt. Ltd., Akorn Pharmaceuticals Inc., Pace Biotech Pvt. Ltd., Wellona Pharma Pvt. Ltd., Kala Pharmaceuticals Inc., Ophdenas Lifesciences Pvt. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/corticosteroid-eyedrops-global-market-report

Which Region Is Projected To Lead The Corticosteroid Eyedrops Market By 2025?

North America was the largest region in the corticosteroid eyedrops market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corticosteroid eyedrops market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25730&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model